Mechanisms of Action and Therapeutic Uses of Thalidomide
A phase I study of CHR-2797, an orally active aminopeptidase inhibitor, in elderly and/or treatment refractory patients with acute myeloid leukemia or.
Presentation
bone marrow
stem cells for lung diseases
Bone marrow
Stable epigenetic reprogramming of bone marrow MSC in patients with MM Sarah Essex.
Chronic myelogenous leukemia. Classification of Myeloid Neoplasms According to the 2008 World Health Organization Classification Scheme.
Chronic myeloid leukemia. ● The myeloproliferative diseases (MPDs) are clonal stem cell disorders characterised by leukocytosis, thrombocytosis, erythrocytosis,
